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3-Phenylethylamino-5, 5-dimethylcyclohex-2-en-l-
one 2 on condensation with arylidenemalononitriles
38-f gives 4-aryl-2-amino-3-cyano-l, 4, 5, 6, 7, 8-
hexahydro-7, 7-dimethyl-5-oxo-N-phenylethylquinolines
48-f. Compound 2 has been synthesized by the reaction
of 5,5-dimethylcyclohexane-l,3-dine l' with 2-phenyl-
ethylamine.
(
Aminoquinolines are found to be associated with
a number of biological activities, viz. analgesic,
anti-inflammatory, antidepressant', hypoglycemic',
antiviral':", gastrointestinal K +/H+ -ATPase inhibi-
tors", gastric secretion inhibitors", anti-Hl'V-I
agents 7, pesticides", antimicrobial", gastric ulcer
inhibitors 10, antiherpetic" and psychoannaleptic'?
agents. Keeping this in view, it was considered of
interest to synthesize some new derivatives of
N -phenylethylquinoline.
We report herein a novel method for the syn-
thesis of 4-aryl-:2-amino-3-cyano-l, 4, $, 6, 7,
8-hexahydto-7, 7-dimethyl- 5-oxo-N -pheriylethyl-
quinolines 4a-f. The method involves the reaction
of 5, 5-dimethylcyc1ohexane-l, 3-dionewith
2-phenylethylamine to give 3-phenylethylamino-5,
5-dimethylcyc1ohex-2-en-l-one 2. Subsequent
condensation of 2 with arylidenemalononitriles
3a-f yields 4-aryl-2-amino-3-cyano-l, 4, 5, 6, 7,
8-hexahydro-7,· 7-dimetnyl- 5-oxo-N -phenylethyl-
quinolines 4a-f.
As 'a typical case, the reaction of 5, 5-dimethyl-
cyc1ohexane-l, 3-dione I with 2-phenylethyla-
mine in benzene using Dean-Starke apparatus
gave a cream coloured crystalline solid in 90%
yield. It was assigned the structure 5, 5-dimethyl-
3-phenylethyiaminocyc1ohex- 2-en-l-one 2
(Scheme I) OQ. the basis of tR and IH NMR spect-
ra.
As a test case, the subsequent cendensation of
2 with 4-methylbenzylidene malononitrlle 3a in















a 4-(CH:3>C6~ d 4-CC°CsHt.
b 2-tNOz)CSH4 e ~H5
c 4 -<OCH3lC6 ~ t 3-(No,;CSH4
Scheme I
forded a cream coloured crystalline solid in 77%
yield. The product was assigned the structure
2-amino-3-cyano-l, 4, 5, 6, 7, 8-hexahydro-7,
7-dimethyl-4-( 4-methylphenyl)-5-oxo-N-phenyle-
thylquinoline 4a (Scheme I) on the basis of ele-
mental analysis and spectral (IR, IH NMR and
mass) data.
Experimental
Melting points are uncorrected. IR spectra were
recorded on a Shimadzu IR-435 infrared spectro-
photometer (Nujol, vmax in em - 1) and 1H NMR
spectra on a Perkin-Elmer R-32 (90 MHz) spec- .
trometer (chemical shifts in a, ppm) using TMS as
an internal standard. Ary)idene malononitrlles 3a-
Iwere prepared by well-known methods.
5, 5-Dimethyl-3-phenylethylaminocyclobex- 2-en-
L-one (2): General procedure. A mixture of 5,
5-dimethylcyclohexane-l, 3-dione (2, 1.0 mmole)
and 2-phenylethylamine (1.0 mmole) in dry ben-
zene (30 mL) was refluxed using Dean-Starke ap-
paratus for 4 hr. The solvent was distilled off and
the residual solid was macerated with petroleum
ether to give cream coloured solid 2 in 90%
yield, m.p. 105-6° (Found: C, 79.24; H, 5.71, N,
8.62. C16H21NO requires C, 79.01; H, 5.76; N.
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Table I-Characterization data of compounds 4b-f
Compd Yield m.p. Mol.fonnula Found % (Calc.) IH NMR rs,ppm)
(%) ·C
C N H
4b* 74 86-87 C26H26N403 70.80 6.01 12.39 1.0(s, 6H, 2 x CH3), 2.0-2.4(m, 4H,
(70.59 5.88 .•, 12.67) 2 x CH2), 3.0(t, 2H,
CH2CH2C6Hs), 3.7(t, 2H,
CH2CH2C6Hs), 4.1(s, 2H, NH2),
5.1(s, IH,CH), 7.0-7.4{~Ir;9H,
Ar-H)
4c· 72 80-81 C27H2~302 75.87 6.82 9.90 1.0(s, 6H, 2 x CH3), 2.0-2.4(m, 4H, I
(75.88 6.79 9.84) 2 x CH2), 2.9(t, 2H,
CH2CH2C6Hs), 3.4(t, 2H,
CH2CH2C6Hs), 3.7(s, 3H, OCH3),
3.9(s, 21i, NH2), 5.2(s, lH, CH),
7.0-8.2(m, 9H, Ar-H)
4d* 83 210-11 C26HN30CI 72.24 5.96 9.64 1.0(s, 6H, 2 x CH3), 2.0-2.3(m, 4H,
(72.31 6.03 9.73) 2 x CH2), 2.9(t, 2H,
CH2CH2C6Hs), 3.5(t, 2H,
CH2CH2C6Hs), 3.9(s, 2H, NH2),
5.1(s, lH, CH), 7.1-7.6(m, 9H, Ar-
H)
4e·· 83 235-36 C26H27N30 78.83 6.63 10.87 1.0(s, 6H, 2 x CH3), 2.0-2.3(m, 4H,
(78.59 6.80 10.58) 2 x CH2), 3.0(t, 2H,
CH2CH2C6Hs), 3.7(t, 2H,
CH2CH2C6Hs), 4.1(s, 2H, NH2),
4.9(s, IH, CH), 7.2-7.7(m, 9H, Ar-
H)
4f** 81 119-20 C26H26N403 70.81 6.09 12.37 1.0(s, 6H, 2 x CH3), 2.0-2.4(m, 4H,
(70.59 5.88 12.67) 2 x CH2), 3.0(t, 2H,
CH2CH2C6Hs), 3.7(t, 2H,
CH2CH2C6Hs), 4.2(s, 2H, NH2),
4.9(s, IH, CH), 7.0-7.5(m, 9H, Ar-
H)
* IH NMR were taken in Acetone-d,
** IH NMR were taken in (CDCI3 + TFA).
8.~%); IR (Nujol); 1710(C=O), 3220 cm-1
(NlI); IH NMR (Pyridine-d.): bl.O(s, 6H,
2 XCH3), 2.2-2.4 (m, 4H, 2 XCH2), 2.9(t, 2H,
CH2CH2C6H5), 3.4(m, 2H, CH2CH2C6H5), 5.5(s,
IH, CH), 6.9-7.2(m, 5H,Ar-H), 7.7(brs, IH, NH,
D20 exchangeable), MS: (m/z) 243 (M+).
2-Amino-3-cyano-l, 4, 5, 6, 7, 8-hexahydro-7,
7-dimetbyl-4-( 4-methylphenyl)-5-oxo-N-phenyle-
tbylquinoline (4&):General procedure. A mixture
of 4-methylbenzylidene malononitrile (3a, 1.0
mmole) and 5, 5-dimethyl-3-phenYlethYlaminocyc-
Iohex-Z-en-l-one (2, 1.0 mmole) in the presence
of absolute ethanol and two drops of pyridine was
refluxed for 12 hr. The solid separated out on
cooling was filtered, washed and recrystallized
with ethanol to give cream coloured crystals of 4a
in 77% yield; m.p. 140-41° (Found: C, 78.64; H,
10.51; N, 7.20. C27H2~30 requires C, 78.83; H,
10.22; N, 7.06%), IR (Nujol): 17lO(C=O), 2200
(C=N), 3380, 3440 cm'! (NH2); IH NMR
(CDCI3 + TFA): si.o (s, 6H, 2 XCH3), 2.0-2.4
(Ill, 7H, CH3, 2 XCH2), 2.9(t, 2H, CH2CH2C6Hs),
3.6{t, 2H, CH2CH2C6H5), 3.9{s, 2H, NH2), 4.9(s,
IH, CH), 7.0-7..4{m, 9H, Ar-H); MS : (m/z)
411{M+).
Similarly, compounds 4b-f were prepared.
Their physical and spectral data are given in
Table I.
Note: After C1Urnote was communicated for
publication a similar reaction was reported 13.
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